3 stories about Biopharmaceuticals
Amotz Shemi Silenseed

Silenseed signs $7.8 million agreement with GIBF to create Chinese subsidiary

05.10.21|James Spiro
Proceeds from the investment are expected to provide Silenseed with liquidity to fund the company’s Phase III clinical trial
ירון פרג מנכל כאהר מדיקל

Cancer Treatment Company KAHR Medical Raises $18 Million

The company intends to use the funding to advance its immuno-oncology drug candidates, especially its lead product, DSP107, tested for the treatment of solid tumors
חדר מיון בית חולים שיבא תל השומר

InSight Biopharmaceuticals Buys Cancer Treatment Company CureTech

28.03.18|Lilach Baumer
As part of the deal, InSight commits to help develop CureTech’s lead product, which is currently in advanced clinical trials